Skip to Main Content


Skip Nav Destination

Abstract A082: Developing a PD-1 based inhibitory chimeric antigen receptor (ICAR) for co-expression, to overcome off-tumor toxicity when targeting ErbB2 using engineered T cells

Cancer Immunol Res (2016) 4 (1_Supplement): A082.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Xianqiang Liu
  • Nan Zhang
  • Huan Shi
Oncotarget (2017) 8 (37): 62730.
  • Ahmed Z. Gad
  • Shahenda El-Naggar
  • Nabil Ahmed
Cytotherapy (2016) 18 (11): 1382.
Close Modal

or Create an Account

Close Modal
Close Modal